New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates In Patients With Rheumatoid Arthritis
14th Nov 2006, 13:31 GMT
Roche today announced the results from two Phase III studies and one Phase II study that showed treatment with the investigational agent tocilizumab -- marketed as ACTEMRA(TM) in Japan for Castleman's Disease -- consistently improved remission rates in patients with rheumatoid arthritis (RA) [click link for full article]
New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates In Patients With Rheumatoid Arthritis related news:
- Actemra™ Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase III Trial Programme — Health News from Medical News Today
- ACR: Aggressive Initial Therapy Can Send Rheumatoid Arthritis Into Remission — MedPage Today Rheumatology
- Early Aggressive Treatment May Alter Course Of Rheumatoid Arthritis — Health News from Medical News Today
- Anti-TNF Golimumab (CNTO 148) Continues To Show Promise In Phase 2 Rheumatoid Arthritis Study — Health News from Medical News Today
- Mayo Clinic information about accelerated aging among people with rheumatoid arthritis — EurekAlert! - Breaking News
- Accelerated Aging Among People With Rheumatoid Arthritis — ScienceDaily Headlines: Health & Medicine
- Turmeric prevents rheumatoid arthritis: US study — NewKerala Health News
- New Information About Accelerated Aging Among People With Rheumatoid Arthritis — Health News from Medical News Today
- Acupuncture helps ease discomfort in rheumatoid arthritis patients — NewKerala Health News
- Rheumatoid Arthritis Patients Receiving Anti-TNF Therapy Can Be Effectively Immunized — Health News from Medical News Today
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes